Literature DB >> 23335515

Scaffold effects on osteogenic differentiation of equine mesenchymal stem cells: an in vitro comparative study.

Rodolfo Nino-Fong1, Laurie A McDuffee, Blanca P Esparza Gonzalez, M Ramesh Kumar, Erika F Merschrod S, Kristin M Poduska.   

Abstract

The in vitro viability, osteogenic differentiation, and mineralization of four different equine mesenchymal stem cells (MSCs) from bone marrow, periosteum, muscle, and adipose tissue are compared, when they are cultured with different collagen-based scaffolds or with fibrin glue. The results indicate that bone marrow cells are the best source of MSCs for osteogenic differentiation, and that an electrochemically aggregated collagen gives the highest cell viability and best osteogenic differentiation among the four kinds of scaffolds studied.
Copyright © 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23335515     DOI: 10.1002/mabi.201200355

Source DB:  PubMed          Journal:  Macromol Biosci        ISSN: 1616-5187            Impact factor:   4.979


  3 in total

1.  Osteogenic potential of sorted equine mesenchymal stem cell subpopulations.

Authors:  Catherine L Radtke; Rodolfo Nino-Fong; Juan Carlos Rodriguez-Lecompte; Blanca P Esparza Gonzalez; Henrik Stryhn; Laurie A McDuffee
Journal:  Can J Vet Res       Date:  2015-04       Impact factor: 1.310

2.  Study of the involvement of allogeneic MSCs in bone formation using the model of transgenic mice.

Authors:  Daria Kuznetsova; Natalia Prodanets; Svetlana Rodimova; Evgeny Antonov; Aleksandra Meleshina; Peter Timashev; Elena Zagaynova
Journal:  Cell Adh Migr       Date:  2016-06-17       Impact factor: 3.405

3.  Osteoblast differentiation of equine induced pluripotent stem cells.

Authors:  Arabella Baird; Timothy Lindsay; Alice Everett; Valentine Iyemere; Yasmin Z Paterson; Alyce McClellan; Frances M D Henson; Deborah J Guest
Journal:  Biol Open       Date:  2018-05-10       Impact factor: 2.422

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.